KRISTIN LEHMANN: Open Payments
NPI 1558951988 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 58 payments from 11 companies in 2025. Trend: 2023 $572 · 2024 $521 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $268 |
| Otsuka America Pharmaceutical, Inc. | 8 | $226 |
| Neurocrine BioSciences, Inc. | 3 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Lundbeck LLC | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: REXULTI, CAPLYTA, INGREZZA, TRINTELLIX, Auvelity, AUSTEDO XR, Jornay PM, SPRAVATO.
Industry payments across VA — which companies pay providers there.
